Related Experiment Video

Updated: Aug 18, 2026

Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow
09:41

Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow

Published on: March 5, 2020

Thrombospondin 1 as possible key factor in the hemocompatibility of endocoronary prostheses

Jan Hoffmann1, Perikles Simon, Anja K Zimmermann

  • 1Department of Thoracic, Cardiac and Vascular Surgery, University Hospital Tuebingen, 72076 Tuebingen, Germany. jan.hoffman@uni-tuebingen.de

Biomaterials
|March 29, 2005
PubMed

Insights

Intracoronary stenting can cause restenosis. This study found Thrombospondin 1 (TSP-1) gene expression in blood cells is an early indicator of immune response after stenting.

Area of Science:

  • Cardiovascular Research
  • Molecular Biology
  • Biomaterials Science

Background:

  • Intracoronary stenting improves coronary artery patency post-percutaneous transluminal coronary angioplasty (PTCA).
  • Despite advances like drug-eluting stents, restenosis due to neointimal hyperplasia, vascular remodeling, and thrombosis remains a significant challenge.
  • Identifying early cellular responses to stenting is crucial for understanding and mitigating restenosis.

Purpose of the Study:

  • To investigate differential gene expression in circulating peripheral blood cells following stent exposure.
  • To identify early activated cellular pathways that may contribute to post-stenting restenosis.
  • To explore Thrombospondin 1 (TSP-1) as a potential early indicator of immune activation.

Main Methods:

  • Human whole blood from healthy volunteers was incubated under flow conditions using a modified Chandler-Loop stent-testing model.
  • Differential gene expression was analyzed using DNA microarrays, comparing stent-exposed cells to resting controls.
  • Over 17,000 genes were simultaneously screened for expression changes.

Main Results:

  • A wide range of genes exhibited differential expression after 90 minutes of stent exposure.
  • Thrombospondin 1 (TSP-1), a key mediator of immune defense, was the most significantly upregulated gene.
  • This suggests TSP-1 activation is an early event in the cellular response to intracoronary stenting.

Conclusions:

  • TSP-1 upregulation serves as an early indicator of immune response activation post-intracoronary stenting.
  • Further in vivo studies are needed to confirm TSP-1's role and its potential as a prognostic factor.
  • TSP-1 research may aid in developing and evaluating more biocompatible stent materials.

More Related Videos

Autologous Endothelial Progenitor Cell-Seeding Technology and Biocompatibility Testing For Cardiovascular Devices in Large Animal Model11:49

Autologous Endothelial Progenitor Cell-Seeding Technology and Biocompatibility Testing For Cardiovascular Devices in Large Animal Model

Published on: September 9, 2011

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood07:08

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood

Published on: September 5, 2017

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...